Structure via PubChem · Public domain (PubChem)
zoledronic acid
Sign in to saveAlso known as ZOL, ZOL446, CGP-42446, CGP-42446A, (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid, (1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid, zoledronic acid anhydrous, Zol
chemical compound
Chemical data
- Formula
- C5H10N2O7P2
- Molecular weight
- 272.09 g/mol
- IUPAC name
- (1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid
- SMILES
- C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
- InChIKey
- XRASPMIURGNCCH-UHFFFAOYSA-N
- XLogP
- -4.3
- Polar surface area
- 153 Ų
- H-bond donors
- 5
- H-bond acceptors
- 8
- Formal charge
- 0
via PubChem
Research
6,636 papers- Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2001
- Zoledronic acid and fracture risk: a meta-analysis of 12 randomized controlled trials.European review for medical and pharmacological sciences · 2021
- Zoledronic acid.Drugs · 2001
- Zoledronic acid for the treatment of prostate cancer.Expert opinion on pharmacotherapy · 2019
- Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma.Current drug targets · 2018
via PubMed
Wikidata facts
- Mass
- 271.996
Show 5 more facts
- chemical formula
- C₅H₁₀N₂O₇P₂
- Commons category
- Zoledronic acid
- canonical SMILES
- C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
- World Health Organisation international non-proprietary name
- zoledronic acid
- defined daily dose
- 4
Sources (8)
via Wikidata · CC0
Connections
intravenous infusion and defusion
Entity
hypocalcaemia
Disease
bisphosphonate
Entity
World Health Organization
Entity
nitrogen
Entity
cancer
Entity
human pregnancy
Entity
bone
Entity
calcium
Entity
medication
Entity
International Standard Book Number
Entity
kidney
Entity
fever
Entity
arterial hypertension
Entity
anemia
Entity
digital object identifier
Entity
breast cancer
Entity
chemical formula
Entity
vitamin D
Entity
osteoporosis
Entity
Categories
BisphosphonatesDrugboxes which contain changes to verified fieldsDrugs developed by NovartisDrugs with non-standard legal statusFarnesyl pyrophosphate synthase inhibitorsImidazolesMultiple chemicals in an infobox that need indexingMultiple chemicals in Infobox drugWorld Health Organization essential medicines